NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice

Medical Microbiology and Immunology

Volumn 205, Issue 5, 2016, Pages 459-470

  Long, Xiaoru ^a   Xie, Jun ^a   Zhao, Keting ^a   Li, Wei ^a   Tang, Wei ^a   Chen, Sisi ^a   Zang, Na ^a   Ren, Luo ^a   Deng, Yu ^a   Xie, Xiaohong ^a   Wang, Lijia ^a   Fu, Zhou ^a   Liu, Enmei ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

AHR; NK cells; Persistent airway inflammation; RSV; Type 2 cytokines

Indexed keywords

GANGLIOSIDE GM1 ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RESVERATROL; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BODY PLETHYSMOGRAPHY; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; INFLAMMATORY CELL; LEUKOCYTE; LUNG PARENCHYMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PERSISTENT INFECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; T CELL DEPLETION; TISSUE INJURY; ANIMAL; CHEMISTRY; CYTOCHEMISTRY; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; LUNG; PATHOLOGY; PLETHYSMOGRAPHY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOCYTOCHEMISTRY; INFLAMMATION; KILLER CELLS, NATURAL; LUNG; MICE, INBRED BALB C; MICE, NUDE; PLETHYSMOGRAPHY; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84975282874     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-016-0459-9     Document Type: Article

References (45)

1. Borchers AT, Chang C, Gershwin ME, Gershwin LJ (2013) Respiratory syncytial virus—a comprehensive review. Clin Rev Allergy Immunol 45(3):331–379. doi:10.1007/s12016-013-8368-9
2. Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV (2015) Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med 191(1):34–44. doi:10.1164/rccm.201405-0901PP
3. Rossi GA, Colin AA (2015) Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing. Eur Respir J 45(3):774–789. doi:10.1183/09031936.00062714
4. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM (2010) Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65(12):1045–1052. doi:10.1136/thx.2009.121582
5. Vercelli D, Gozdz J, von Mutius E (2014) Innate lymphoid cells in asthma: when innate immunity comes in a Th2 flavor. Curr Opin Allergy Clin Immunol 14(1):29–34. doi:10.1097/ACI.0000000000000023
6. Kim BS, Wojno ED, Artis D (2013) Innate lymphoid cells and allergic inflammation. Curr Opin Immunol 25(6):738–744. doi:10.1016/j.coi.2013.07.013
7. Milush JM, Long BR, Snyder-Cappione JE, Cappione AJ III, York VA, Ndhlovu LC, Lanier LL, Michaëlsson J, Nixon DF (2009) Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood 114(23):4823–4831. doi:10.1182/blood-2009-04-216374
8. Wingett D, Nielson CP (2003) Divergence in NK cell and cyclic AMP regulation of T cell CD40L expression in asthmatic subjects. J Leukoc Biol 74(4):531–541
9. Werner JM, Busl E, Farkas SA, Schlitt HJ, Geissler EK, Hornung M (2011) DX5 + NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1 + C57Bl/6 mice. BMC Immunol 12:26. doi:10.1186/1471-2172-12-26
10. Culley FJ (2009) Natural killer cells in infection and inflammation of the lung. Immunology 128(2):151–163. doi:10.1111/j.1365-2567.2009.03167.x
11. Karimi K, Forsythe P (2013) Natural killer cells in asthma. Front Immunol 4:159. doi:10.3389/fimmu.2013.00159.eCollection
12. Hussell T, Openshaw PJ (2000) IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J Immunol 165(12):7109–7115
13. Li F, Zhu H, Sun R, Wei H, Tian Z (2012) Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol 86(4):2251–2258. doi:10.1128/JVI.06209-11
14. Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, Tregoning JS, Caspi RR, Bukreyev A, Collins PL, Openshaw PJ (2010) Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. J Virol 84(8):4073–4082. doi:10.1128/JVI.02014-09
15. Mathias CB (2015) Natural killer cells in the development of asthma. Curr Allergy Asthma Rep 15(2):500. doi:10.1007/s11882-014-0500-2
16. Ple C, Barrier M, Amniai L, Marquillies P, Bertout J, Tsicopoulos A, Walzer T, Lassalle P, Duez C (2010) Natural killer cells accumulate in lung-draining lymph nodes and regulate airway eosinophilia in a murine model of asthma. Scand J Immunol 72(2):118–127. doi:10.1111/j.1365-3083.2010.02419.x
17. Mathias CB, Guernsey LA, Zammit D, Brammer C, Wu CA, Thrall RS, Aguila HL (2014) Pro-inflammatory role of natural killer cells in the development of allergic airway disease. Clin Exp Allergy 44(4):589–601. doi:10.1111/cea.12271
18. Wei H, Zhang J, Xiao W, Feng J, Sun R, Tian Z (2005) Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol 115(4):841–847
19. Farhadi N, Lambert L, Triulzi C, Openshaw PJ, Guerra N, Culley FJ (2014) Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation. J Allergy Clin Immunol 133(3):827–835.e3. doi:10.1016/j.jaci.2013.09.048
20. Zhang Z, Burnley P, Coder B, Su DM (2012) Insights on FoxN1 biological significance and usages of the “nude” mouse in studies of T-lymphopoiesis. Int J Biol Sci 8(8):1156–1167. doi:10.7150/ijbs.5033
21. Zhou J, Yang XQ, Fu Z, Zhao XD, Jiang LP, Wang LJ, Cui YX (2008) Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice. Med Microbiol Immunol 197(4):345–351
22. Long X, Li S, Xie J, Li W, Zang N, Ren L, Deng Y, Xie X, Wang L, Fu Z, Liu E (2015) MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice. Respir Res 16:11. doi:10.1186/s12931-015-0176-8
23. Zang N, Li S, Li W, Xie X, Ren L, Long X, Xie J, Deng Y, Fu Z, Xu F, Liu E (2015) Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice. Int Immunopharmacol 28(1):121–128. doi:10.1016/j.intimp.2015.05.031
24. Harker JA, Yamaguchi Y, Culley FJ, Tregoning JS, Openshaw PJ (2014) Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system. J Virol 88(1):604–611. doi:10.1128/JVI.02620-13
25. Deng Y, Chen W, Zang N, Li S, Luo Y, Ni K, Wang L, Xie X, Liu W, Yang X, Fu Z, Liu E (2011) The antiasthma effect of neonatal BCG vaccination does not depend on the Th17/Th1 but IL-17/IFN-γ balance in a BALB/c mouse asthma model. J Clin Immunol 31(3):419–429. doi:10.1007/s10875-010-9503-5
26. Trung LQ, Espinoza JL, Takami A, Nakao S (2013) Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition. PLoS ONE 8(1):e55183. doi:10.1371/journal.pone.0055183
27. Estripeaut D, Torres JP, Somers CS, Tagliabue C, Khokhar S, Bhoj VG, Grube SM, Wozniakowski A, Gomez AM, Ramilo O, Jafri HS, Mejias A (2008) Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 198(10):1435–1443. doi:10.1086/592714
28. Liu Y, Zhang S, Li DW, Jiang SJ (2013) Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials. PLoS ONE 8(3):e59872. doi:10.1371/journal.pone.0059872
29. Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, Wilkins HJ, Henkel T, Nair P, Res-5-0010 Study Group (2011) Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 184(10):1125–1132. doi:10.1164/rccm.201103-0396OC
30. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365(12):1088–1098. doi:10.1056/NEJMoa1106469
31. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, Hamilton J, Ming JE, Radin A, Stahl N, Yancopoulos GD, Graham N, Pirozzi G (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368(26):2455–2466. doi:10.1056/NEJMoa1304048
32. Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG (2013) Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. J Allergy Clin Immunol 132(3):567–574.e12. doi:10.1016/j.jaci.2013.03.051
33. Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O’Byrne PM, Gauvreau GM, Boulet LP, Lemiere C, Martin J, Nair P, Sehmi R (2015) Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol. doi:10.1016/j.jaci.2015.05.037
34. Ozyigit LP, Morita H, Akdis M (2015) Innate lymphocyte cells in asthma phenotypes. Clin Transl Allergy 5:23. doi:10.1186/s13601-015-0068-5
35. Agache I, Sugita K, Morita H, Akdis M, Akdis CA (2015) The complex type 2 endotype in allergy and asthma: from laboratory to bedside. Curr Allergy Asthma Rep 15(6):29. doi:10.1007/s11882-015-0529-x
36. Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, Benoit LA, Byers DE, Alevy Y, Tucker J, Swanson S, Tidwell R, Tyner JW, Morton JD, Castro M, Polineni D, Patterson GA, Schwendener RA, Allard JD, Peltz G, Holtzman MJ (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 14(6):633–640. doi:10.1038/nm1770
37. Lu CC, Chen JK (2010) Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. J Cell Physiol 223(2):343–351. doi:10.1002/jcp.22043
38. Li Q, Huyan T, Ye LJ, Li J, Shi JL, Huang QS (2014) Concentration-dependent biphasic effects of resveratrol on human natural killer cells in vitro. J Agric Food Chem 62(45):10928–10935. doi:10.1021/jf502950u
39. Chen G, Tang J, Ni Z, Chen Q, Li Z, Yang W, Din J, Luo X, Wang X (2015) Antiasthmatic effects of resveratrol in ovalbumin-induced asthma model mice involved in the upregulation of PTEN. Biol Pharm Bull 38(4):507–513. doi:10.1248/bpb.b14-00610
40. Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH, Tsai TF (2012) Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res (Phila) 5(7):952–962. doi:10.1158/1940-6207.CAPR-12-0001
41. Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I (2013) Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol 183(5):1390–1396. doi:10.1016/j.ajpath.2013.07.006
42. Aktas E, Akdis M, Bilgic S, Disch R, Falk CS, Blaser K, Akdis C, Deniz G (2005) Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol 140:301–309. doi:10.1111/j.1365-2249.2005.02777.x
43. Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, Moretta L, Vitale M (2008) Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol 121:479–485. doi:10.1016/j.JACI.2007.09.047
44. Nishikado H, Mukai K, Kawano Y, Minegishi Y, Karasuyama H (2011) NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo. J Immunol 186:5766–5771. doi:10.4049/jimmunol.1100370
45. Slifka MK, Pagarigan RR, Whitton JL (2000) NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 164(4):2009–2015